Diabetes Flashcards
Correction factor rapid insulin
1800/TDD
Nesina generic and MOA
Alogliptin DPP-4
Avandia generic and MOA
Rosiglitazone TZD
Linagliptin MOA
DPP-4
Saxagliptin MOA
DPP-4
Dapagliflozin MOA
SGLT2
Basaglar RT stability
28 days
Correction factor regular insulin
1500/TDD
SGLT2 CI
eGFR <30
toujeo to lantus or basaglar conversion
80% of total daily toujeo
Meds with weight loss and no hypoglycemia
metformin
GLP-1
SGLT2
Ozempic generic and MOA
semaglutie GLP-1
Onglyza generic and MOA
Saxagliptin DPP-4
Starlix generic and MOA
Nateglinide meglitinide
Alogliptin MOA
DPP-4
TZD ending
glitazone
Glyburide MOA
Sulfonylurea
Sitagliptin MOA
DPP-4
Humalog RT stability
28 days
Tradjenta generic and MOA
Linagliptin DPP-4
Novolog RT stability
28 days
Empagliflozin MOA
SGLT2
long acting insulin
glargine - lantus
detemir - levemir
degludec - tresiba
Januvia generic and MOA
sitagliptin DPP-4
Glimiperide MOA
sulfonylurea
Prandin generic and MOA
repaglinide meglitinide
Invokana generic and MOA
canagliflozin SGLT2
Toujeo RT stability
56 days
Amaryl generic and MOA
glimperide sulfonylurea
TZD warnings
fractures
edema
hepatic failure
Pioglitazone: bladder cancer
Semaglutide MOA
GLP-1
Byetta generic and MOA
exenatide GLP-1
Glipizide MOA
Sulfonylurea
DPP-4 warnings
Pancreatitis
arthralgia
renal failure
Pioglitazone MOA
TZD
Rapid acting insulin
aspart - Novolog
lispro - humalog
glulisine - apidra
SGLT2 warnings
UTIs, fungal infections
hyperK
fluid loss
ketoacidosis
cana: fractures
Dapa: bladder cancer
Metformin CI
eGFR <30
Metabolic acidosis
Repaglinide MOA
meglitinide
Jardiance generic and MOA
Empagliflozing SGLT2
Increase gastric emptying
GLP-1
Pramlinitide
BW for GLP-1
thyroid cancer
GLP-1 ending
tide
SGLT2 ending
flozin
Liraglutide MOA
GLP-1
short acting insulin
regular insulin
Do not use together
DPP-4 + GLP-1
Insulin + sulfonylurea
Lantus RT stablility
28 days
Nateglinide MOA
meglinide
a1c 10% = ____BG
240
Meal time dosing rapid insulin
500/TDD
Sulfonylurea ending
g-ide
Rosiglitazone MOA
TZD
Levemir RT stability
42 days
BID NPH to glargine conversion
80% of total daily NPH
Tresiba RT stability
56 days
Actos generic and MOA
Pioglitazone TZD
Increase glucose excretion
SGLT2
TZD CI
NYHA III/IV
Intermediate insuline
NPH
a1c to BG calculation
+/- 14
Warnings GLP-1
pancreatitis
gallbladder disease
Bydureon generic and MOA
exanatide GLP-1
Victoza generic and MOA
liraglutide GLP-1
Canaglaflozin MOA
SGLT2
DPP-4 ending
gliptin
Trulicity generic and MOA
dulaglutide GLP-1
Meglitinides
glinide
Farxiga generic and MOA
Dapagliflozin SGLT2
Dulaglutide MOA
GLP-1
Adlyxin generic and MOA
lixisenatide GLP-1
Glucotrol generic and MOA
Glipizide sulfonylurea
Drugs that increase BG
beta blockers diuretics tacrolimus Protease inhibitors quinolones antipsychotics statins steroids cough syrups niacin
Glynase generic and MOA
glyburide sulfonylurea
T1D starting insulin
0.5 U/kg/day
50% basal, 50% bolus
Meal time dosing regular insulin
450/TDD